Skip To Main Content
Anis Barmada on Muck Rack

Anis Barmada

As seen in: Nature, Wiley Online Library, Yahoo Canada, Aol, Scientific American, The Hill, Flipboard, Genome Medicine, Science Magazine, STAT and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anis

Contact Anis, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Viewpoint: No, we should not follow RFK, Jr.’s recommendation and quickly phase out biomedical research animal testing 

|
By Anis Barmada
| Genetic Literacy Project
GLP Policy & Performance Review, 2024 The GLP is committed to full transparency. Download the report. Global Gene Editing Regulation Tracker Our interactive GLP global map explains the status of each country’s regulations for human and agricultural gene editing and gene drives. GLP 2021 Annual Report The GLP is committed to full transparency. Download our 2021 Annual Report.
Open in Who Shared Issue with article?

Modern animal models for biomedical research remain far better than alternatives

|
By Anis Barmada
| Flipboard
Billion, trillion...who's counting anymore? How do you become the world's first trillionaire? If you thought it's by working hard, saving every penny and making your own lattes instead of buying them at Starbucks, we have news that may disappoint you. On Thursday, during the company's Annual …
Open in Who Shared View Duplicates (22) Issue with article?

How cutting animal testing jeopardizes human health Original

|
By Anis Barmada
| The Hill Verified
The Food and Drug Administration and National Institutes of Health held a joint workshop July 7 on reducing animal testing in research, strikingly announcing that “NIH will no longer seek proposals exclusively for animal models.” This change follows the FDA’s plan to phase out the requirement for animal testing of drugs, which marked the beginning of an overall shift away from animal research to what the new leadership refers to as “more effective, human-relevant methods.” What this means is...
Open in Who Shared View Duplicates (5) Issue with article?
See all 10 licensed articles (12 Total)